Market Overview - The animal health sector experienced a decline of 0.21% on September 12, with Dayu Biological leading the drop [1] - The Shanghai Composite Index closed at 3883.69, up 0.22%, while the Shenzhen Component Index closed at 12996.38, up 0.13% [1] Individual Stock Performance - Shunlian Biological (688098) closed at 11.85, up 2.07% with a trading volume of 85,100 shares and a turnover of 99.05 million yuan [1] - KQ Biological (688526) closed at 18.63, up 0.70% with a trading volume of 19,700 shares and a turnover of 36.27 million yuan [1] - Huisheng Biological (300871) closed at 22.55, up 0.53% with a trading volume of 54,100 shares and a turnover of 122 million yuan [1] - Dayu Biological (871970) led the decline, closing at 10.73, down 3.85% with a trading volume of 76,600 shares and a turnover of 82.31 million yuan [2] Capital Flow Analysis - The animal health sector saw a net outflow of 15.44 million yuan from institutional investors, while retail investors experienced a net outflow of 9.04 million yuan [2] - Speculative funds recorded a net inflow of 24.47 million yuan [2] Detailed Capital Flow for Selected Stocks - Shunlian Biological had a net inflow of 14.94 million yuan from institutional investors, but a net outflow of 21.09 million yuan from retail investors [3] - Huisheng Biological experienced a net outflow of 7.83 million yuan from institutional investors, while retail investors had a net inflow of 9.81 million yuan [3] - KQ Biological saw a net outflow of 1.73 million yuan from institutional investors, with a minor net inflow from retail investors [3]

Core Viewpoint - The animal health sector experienced a rise of 0.92% on September 11, with Dayu Biological leading the gains, while the overall market indices also showed significant increases [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3875.31, up 1.65%, and the Shenzhen Component Index closed at 12979.89, up 3.36% [1]. - Dayu Biological's stock price increased by 3.81% to 11.16, with a trading volume of 140,500 shares and a transaction value of 158 million [1]. Group 2: Individual Stock Performance - Other notable performers included: - Houfeng Holdings, up 2.75% to 4.11, with a trading volume of 326,800 shares and a transaction value of 133 million [1]. - Keqian Biological, up 2.15% to 18.50, with a trading volume of 32,400 shares and a transaction value of 59.27 million [1]. - Yongshun Biological, up 1.69% to 10.80, with a trading volume of 48,100 shares and a transaction value of 52.46 million [1]. Group 3: Capital Flow Analysis - The animal health sector saw a net outflow of 70.71 million from institutional investors, while retail investors contributed a net inflow of 77.65 million [2][3]. - The capital flow for individual stocks showed varied trends, with significant outflows from stocks like Zhongmu Co., which had a net outflow of 11.86 million from institutional investors [3].

Market Overview - The animal health sector experienced a decline of 0.5% on September 10, with Yongshun Biological leading the drop [1] - The Shanghai Composite Index closed at 3812.22, up 0.13%, while the Shenzhen Component Index closed at 12557.68, up 0.38% [1] Stock Performance - Notable gainers included: - Qudongli (838275) with a closing price of 11.21, up 2.75% [1] - *ST Lvkang (002868) at 26.42, up 1.62% [1] - Houfeng Holdings (002141) at 4.00, up 0.76% [1] - Major decliners included: - Yongshun Biological (839729) at 10.62, down 3.28% [2] - Shilian Biological (688098) at 11.72, down 1.76% [2] - Huai Sheng Biological (300871) at 22.20, down 1.60% [2] Capital Flow Analysis - The animal health sector saw a net outflow of 81.6 million yuan from institutional investors, while retail investors contributed a net inflow of 53.0 million yuan [2] - The detailed capital flow for key stocks showed: - Repu Biological (300119) had a net inflow of 1.12 million yuan from retail investors [3] - Kexian Biological (688526) saw a net inflow of 14.78 thousand yuan from institutional investors [3] - Hai Li Biological (603718) experienced a significant net outflow of 22.66 million yuan from institutional investors [3]

Group 1 - The controlling shareholder of *ST Lvkang, Shanghai Kangyi Investment Co., Ltd., holds 47,291,400 shares, accounting for 30.43% of the total share capital [1] - The recent pledge extension involves 5,200,000 shares, representing 11.00% of the shares held by the controlling shareholder and 3.35% of the total share capital [1] - After the pledge extension, the total pledged shares by the controlling shareholder and its concerted parties amount to approximately 10.34 million shares, which is 21.08% of their holdings and 6.65% of the total share capital [1] Group 2 - For the first half of 2025, *ST Lvkang's revenue composition is as follows: veterinary medicine 61.79%, photovoltaic film 26.1%, biopesticides 5.99%, others 2.83%, and food additives 2.19% [1] - As of the report date, *ST Lvkang's market capitalization is 4.1 billion [1]

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-092 | | （股） | | | | | | 比例 | 比例 | | | | 售和冻 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 数 量 | | 数 | 量 | | | 结、标 | | | | | | 股 | | 股份 | | | | | | | | | 结数量 | | | | | | | （股） | | （股） | | | | | 记数量 | | | | | 份 | | 比例 | | | | | | | | | | | | | | | | | | | | | | | | （股） | | | | | | | | | | | | | （股） | 比 | | | | | | | | | | | | | | 例 | | | | | | 上海 | 47,291,4 | 30.43 | 10,335, | | 10,335,1 | | | | | | | | | | 康怡 | 00 | % | | 1 ...

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-092 绿康生化股份有限公司 关于控股股东部分股票质押展期的公告 公司控股股东及本公司董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 公司于近日收到控股股东上海康怡的通知，获悉其所持有的本公司部分股票办理了 质押展期，具体事项如下： 一、股东股份质押的基本情况 1. 本次股东股份质押展期基本情况 | 是否为 | 是 | 是 | 控股股 | 否 | | | | | | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股 | 否 | 展期 | 质 | 东或第 | 本期质押 | 占其所 | 占公司 | 为 | 质押 | 质押 | 东 | 为 | 后质 | 质权 | 押 | | | | | | | | | | ...

Market Overview - The animal health sector increased by 1.25% on September 5, with Yongshun Biological leading the gains [1] - The Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] Stock Performance - Yongshun Biological (839729) closed at 10.82, up 4.14% with a trading volume of 44,500 shares and a turnover of 47.80 million yuan [1] - Shilian Biological (688098) closed at 11.76, up 3.16% with a trading volume of 114,100 shares and a turnover of 132 million yuan [1] - Other notable performers include: - Houfeng Holdings (002141): closed at 3.96, up 2.33% [1] - KQ Biological (688526): closed at 18.00, up 2.16% [1] - Dayu Biological (871970): closed at 10.25, up 2.09% [1] Capital Flow - The animal health sector experienced a net outflow of 37.19 million yuan from institutional investors, while retail investors saw a net inflow of 13.24 million yuan [2] - Notable capital flows include: - Shilian Biological: net inflow of 500.11 thousand yuan from institutional investors [3] - Houfeng Holdings: net inflow of 91.15 thousand yuan from retail investors [3] - KQ Biological: net outflow of 297.54 thousand yuan from institutional investors [3]

Market Overview - The animal health sector experienced a decline of 0.2% on September 4, with Shunlian Biological leading the drop [1] - The Shanghai Composite Index closed at 3765.88, down 1.25%, while the Shenzhen Component Index closed at 12118.7, down 2.83% [1] Stock Performance - Notable gainers in the animal health sector included: - Qudongli (code: 838275) with a closing price of 11.96, up 6.50% [1] - Dayu Biological (code: 871970) with a closing price of 10.04, up 3.40% [1] - Yongshun Biological (code: 839729) with a closing price of 10.39, up 2.26% [1] - Conversely, Shunlian Biological (code: 688098) saw a decline of 2.98%, closing at 11.40 [2] Trading Volume and Capital Flow - The total trading volume for the animal health sector showed a net outflow of 85.41 million yuan from institutional investors, while retail investors saw a net inflow of 74.17 million yuan [2] - The capital flow for individual stocks indicated significant movements, with Shunlian Biological experiencing a net outflow of 10.12 million yuan from institutional investors [3] Individual Stock Analysis - Shunlian Biological had a total trading volume of 131,200 shares, with a net inflow of 7.73 million yuan from retail investors [3] - Other stocks like Huisheng Biological (code: 300871) and ST Green Kang (code: 002868) also showed varied capital flows, with Huisheng experiencing a net outflow of 12.50 million yuan from speculative funds [3]

Core Viewpoint - The announcement details that a significant shareholder of Green康生化股份有限公司 has had part of their shares frozen, but this will not affect the company's control or daily operations [1][2]. Group 1: Shareholder Information - The shareholder involved is Mr. Dong Hai and Xiamen International Trust Co., Ltd., who collectively had 1,500,000 shares frozen, representing 19.30% of their holdings and 0.97% of the company's total share capital [1][2]. - The total share capital of the company is noted to be 5%, and the frozen shares do not belong to the largest shareholder or actual controller [1][2]. Group 2: Impact on Company Operations - The freezing of shares will not lead to a change in the actual controller of the company and will not impact the company's daily operations or management [2][3]. - The company maintains independence in assets, business, and financial aspects from the involved shareholders, ensuring that governance and daily operations remain unaffected [3].

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-091 绿康生化股份有限公司 关于持股 5%以上股东部分股份被冻结的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1、截至本公告披露日，董海先生持有公司非限售流通股票 7,770,792 股，占 公司总股本比例为 5%，非公司第一大股东、控股股东或实际控制人及其一致行 动人，未在公司及下属子公司担任董事、监事、高级管理人员等职务。本次被司 法冻结股份 1,500,000 股，占其所持公司股份比例为 19.30%，占公司总股本比例 为 0.97%。其累计被冻结股份 1,500,000 股，占其所持公司股份比例为 19.30%， 占公司总股本比例为 0.97%。 2、截至本公告披露日，厦门国际信托持有公司非限售流通股票 7,770,792 股， 占公司总股本比例为 5%，非公司第一大股东、控股股东或实际控制人及其一致 行动人。本次被司法冻结股份 1,500,000 股，占其所持公司股份比例为 19.30%， 占公司总股本比例为 0.97%。其累计被冻结股份 1,500,000 股，占其所持 ...